Mebhydrolin: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name | | Verifiedfields = changed | ||
| image | | Watchedfields = changed | ||
| verifiedrevid = 462100967 | |||
| IUPAC_name = 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1''H''-pyrido[4,3-''b'']indole | |||
| image = Mebhydroline.png | |||
| | <!--Clinical data--> | ||
| | | tradename = | ||
| Drugs.com = {{drugs.com|international|mebhydrolin}} | |||
| pregnancy_category = Not established<ref name="Intekom">{{cite web | url = http://home.intekom.com/pharm/bayer/fabahist.html | title = FABAHISTIN 50 mg (Tablets) | date = September 1970 | accessdate = 2007-03-02 | work = South African Electronic Package Inserts}} {{Dead link|date=October 2010|bot=H3llBot}}</ref> | |||
| pregnancy_category= | |||
| routes_of_administration = oral<ref name="Intekom"/> | | routes_of_administration = oral<ref name="Intekom"/> | ||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|changed|??}} | |||
| CAS_number = 524-81-2 | |||
| CAS_supplemental = 6153-33-9<ref name="MeSH diazoline">{{cite web | url = http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?mode=&term=diazoline | title = Diazoline | publisher = US National Institutes of Health, National Library of Medicine | accessdate = 2007-03-02 | work = National Library of Medicine - Medical Subject Headings}}</ref> | |||
| ATC_prefix = R06 | |||
| ATC_suffix = AX15 | |||
| PubChem = 22530 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 21129 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 9SUK9B7XVY | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D08161 | |||
<!--Chemical data--> | |||
| C=19 | H=20 | N=2<ref name="ChemIndustry">{{cite web | url = http://www.chemindustry.com/chemicals/969111.html | title = Mebhydrolin chemical information | accessdate = 2007-03-02 | work = PubChem}}</ref> | |||
| molecular_weight = 276.376 g/mol | |||
| smiles = CN3Cc4c1ccccc1n(Cc2ccccc2)c4CC3 | |||
| InChI = 1/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3 | |||
| InChIKey = FQQIIPAOSKSOJM-UHFFFAOYAM | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = FQQIIPAOSKSOJM-UHFFFAOYSA-N | |||
| synonyms = 9-Benzyl-2-methyl-2,3,4,9-tetrahydro-1H-gamma-carboline, Incidal, Omeril, diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate<ref name="MeSH mebhydroline">{{cite web | url = http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?mode=&term=mebhydroline | title = Mebhydroline | publisher = US National Institutes of Health, National Library of Medicine | accessdate = 2007-03-02 | work = National Library of Medicine - Medical Subject Headings}}</ref> | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
{{ | |||
==Overview== | ==Overview== | ||
'''Mebhydrolin''' ([[International Nonproprietary Name|INN]]) or '''mebhydroline''' is an [[antihistamine]]. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis. | '''Mebhydrolin''' ([[International Nonproprietary Name|INN]]) or '''mebhydroline''' is an [[antihistamine]]. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis. | ||
Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.<ref>{{cite | Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.<ref>{{cite journal |author=Franks HM, Lawrie M, Schabinsky VV, Starmer GA, Teo RK |title=Interaction between ethanol and antihistamines: 3. mebhydrolin |journal=Med. J. Aust. |volume=2 |issue=9 |pages=477–9 |date=October 1981 |pmid=6119605 }}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{Antihistamines}} | {{Antihistamines}} | ||
[[Category: | [[Category:H1 receptor antagonists]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 18:12, 8 April 2015
Clinical data | |
---|---|
Synonyms | 9-Benzyl-2-methyl-2,3,4,9-tetrahydro-1H-gamma-carboline, Incidal, Omeril, diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate[2] |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | oral[1] |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H20N2[4] |
Molar mass | 276.376 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Mebhydrolin |
Articles |
---|
Most recent articles on Mebhydrolin Most cited articles on Mebhydrolin |
Media |
Powerpoint slides on Mebhydrolin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Mebhydrolin at Clinical Trials.gov Clinical Trials on Mebhydrolin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Mebhydrolin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Mebhydrolin Discussion groups on Mebhydrolin Patient Handouts on Mebhydrolin Directions to Hospitals Treating Mebhydrolin Risk calculators and risk factors for Mebhydrolin
|
Healthcare Provider Resources |
Causes & Risk Factors for Mebhydrolin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mebhydrolin (INN) or mebhydroline is an antihistamine. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis.
Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.[5]
References
- ↑ 1.0 1.1 "FABAHISTIN 50 mg (Tablets)". South African Electronic Package Inserts. September 1970. Retrieved 2007-03-02.[dead link]
- ↑ "Mebhydroline". National Library of Medicine - Medical Subject Headings. US National Institutes of Health, National Library of Medicine. Retrieved 2007-03-02.
- ↑ "Diazoline". National Library of Medicine - Medical Subject Headings. US National Institutes of Health, National Library of Medicine. Retrieved 2007-03-02.
- ↑ "Mebhydrolin chemical information". PubChem. Retrieved 2007-03-02.
- ↑ Franks HM, Lawrie M, Schabinsky VV, Starmer GA, Teo RK (October 1981). "Interaction between ethanol and antihistamines: 3. mebhydrolin". Med. J. Aust. 2 (9): 477–9. PMID 6119605.
- Pages with script errors
- All articles with dead external links
- Articles with dead external links from October 2010
- Articles with invalid date parameter in template
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with erroneous molar mass calculations
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- H1 receptor antagonists
- Drug